FDA Accepts NDA Filing for Cleviprex(TM) for the Treatment of Acute Hypertension
- Details
- Category: Product
![The Medicines Company The Medicines Company](http://www.worldpharmanews.com/images/stories/logo/themedicines.gif)
Merck & Co., Inc. Announces Completion of NovaCardia, Inc. Acquisition
- Details
- Category: Merck
![Merck & Co., Inc. Merck & Co., Inc.](http://www.worldpharmanews.com/images/stories/logo/merk.gif)
FDA Advisory Committees Recommend Continued US Marketing Authorization for Trasylol
- Details
- Category: Bayer
![Bayer Bayer](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits
- Details
- Category: Sanofi
![sanofi-aventis sanofi-aventis](http://www.worldpharmanews.com/images/stories/logo/sanofi-avenits.gif)
Global Phase III Trial to Evaluate Sunitinib Malate Combined with Erlotinib
- Details
- Category: Pfizer
![Pfizer Pfizer](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
ERBITUX® Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Bristol-Myers Squibb](http://www.worldpharmanews.com/images/stories/logo/bms.gif)
PLIVA Enters Oncology Business in Germany
- Details
- Category: Financial
![PLIVA d.d. PLIVA d.d.](http://www.worldpharmanews.com/images/stories/logo/pliva.gif)
More Pharma News ...
- Novo Nordisk is Rated Supersector Leader in the 2007 Dow Jones Sustainability Indexes
- Dow Jones Sustainability Index Again Recognizes Abbott
- Avastin approved in Europe for first-line treatment of patients with advanced lung cancer
- CeNeS and ERGOMED Report Start of Recruitment for Phase II trial of CNS 5161 in cancer pain
- AstraZeneca and Pozen To Start Phase III Trials With PN400
- Bayer intends to delist from the New York Stock Exchange
- Novartis to defend its intellectual property rights for Famvir®